$PEPG has been mentioned 7 times over the past 12 months by 2 distinct FinTwit voices, with the first mention appearing on March 4, 2026. @investmentguru_ leads discussion with 4 mentions, followed by @adamfeuerstein with 3 mentions. The most recent activity occurred on March 30, 2026, when mixed trial data drove discussion of the stock trading at $2.38 in after-hours trading.

The conversation around $PEPG centers on clinical trial outcomes and trial design methodology. @investmentguru_ noted the stock's after-hours movement on mixed trial data, while @adamfeuerstein focused on trial sample size concerns, observing that the company appears to be a RA Capital holding and raising questions about how exclusion criteria might affect trial results and interpretation.